Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_62342145bbc9de1528a2cef8ee2e9216 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-156 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-118 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C40B40-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6886 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C40B40-06 |
filingDate |
2015-09-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5a9582897ac2ef0ac951504c1daab887 |
publicationDate |
2016-04-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
WO-2016049694-A1 |
titleOfInvention |
Methods for assessing risk of developing breast cancer |
abstract |
The present disclosure relates to methods and systems for assessing the risk of a human female subject for developing breast cancer. In particular, the present disclosure relates to combining clinical risk assessment and genetic risk assessment to improve risk analysis, wherein the genetic risk assessment comprises screening at least (72) single nucleotide polymorphisms (SNPs) disclosed herein, or SNPs in linkage disequilibrium with one or more thereof. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3695015-A4 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2019071322-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2018136995-A1 |
priorityDate |
2014-09-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |